RT Journal Article SR Electronic T1 Tracing the transmission of carbapenem-resistant Enterobacterales at the patient:ward environmental nexus JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.07.03.24309291 DO 10.1101/2024.07.03.24309291 A1 Elton, Linzy A1 Williams, Alan A1 Ali, Shanom A1 Heaphy, Jelena A1 Pang, Vicky A1 Commins, Liam A1 O’Brien, Conor A1 Yetiş, Özge A1 Caine, Estelle A1 Ward, Imogen A1 Muzslay, Monika A1 Yui, Samuel A1 Karia, Kush A1 Shore, Ellinor A1 Rofael, Sylvia A1 Mack, Damien A1 McHugh, Timothy D A1 Wey, Emmanuel Q YR 2024 UL http://medrxiv.org/content/early/2024/07/05/2024.07.03.24309291.abstract AB Introduction Colonisation and infection with Carbapenem-resistant Enterobacterales (CRE) in healthcare settings poses significant risks, especially for vulnerable patients. Genomic analysis can be used to trace transmission routes, supporting antimicrobial stewardship and informing infection control strategies. Here we used genomic analysis to track the movement and transmission of CREs within clinical and environmental samples.Methods 25 isolates were cultured from clinical patient samples or swabs, that tested positive for OXA-48-like variants using the NG-Test® CARBA-5 test and whole genome sequenced (WGS) using Oxford Nanopore Technologies (ONT). 158 swabs and 52 wastewater samples were collected from the ward environment. 60 isolates (matching clinical isolate genera; Klebsiella, Enterobacter, Citrobacter and Escherichia) were isolated from the environmental samples. Metagenomic sequencing was undertaken on 36 environmental wastewater and swab samples.Results 21/25 (84%) clinical isolates had >1 blaOXA gene and 19/25 (76%) harboured >1 blaNDM gene. Enterobacterales were most commonly isolated from environmental wastewater samples 27/52 (51.9%), then stick swabs 5/43 (11.6%) and sponge swabs 5/115 (4.3%). 11/60 (18%) environmental isolates harboured at >1 blaOXA gene and 1.9% (1/60) harboured blaNDM-1. blaOXA genes were found in 2/36 (5.5%) metagenomic environmental samples.Discussion Potential for putative patient-patient and patient-ward transmission was shown. ONT sequencing can expedite clinical decisions whilst awaiting reference laboratory results, providing economic and patient care benefits. Metagenomic sampling needs optimization to improve sensitivity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the Royal Free London NHS Foundation TrustAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This diagnostic service evaluation was undertaken at the request of the Division of Nursing in support of the Infection Prevention and Control team as part of enhanced standard of care practices for IPC outbreak investigation. This project is under HRA approval for ELCID and registered with Health Services London. IRAS project ID: 283831, National HRA REC reference: 20/HRA/4928, Local REC: RFL R&D ref: 134895, HSL Project number: 1529I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript or available online under ENA bioproject number PRJEB76684. For patient and ward metadata, please contact the authors.AMRAntimicrobial resistanceASTAntibiotic sensitivity testCRECarbapenem-resistant EnterobacteralesDWTDrain waste trapHCAIHealthcare associated infectionHWBHand wash basinIPCInfection prevention and controlMDROMulti-drug resistant organismNDMNew Delhi metallo-beta lactamaseONTOxford Nanopore TechnologiesRDTRapid diagnostic testSDStandard deviationWoWWorkstation on wheels